- Home
- PSNY vs RXRX Comparison
PSNY vs RXRX Comparison
Compare PSNY & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNY
- RXRX
- Stock Information
- Founded
- PSNY 2017
- RXRX 2013
- Country
- PSNY Sweden
- RXRX United States
- Employees
- PSNY N/A
- RXRX N/A
- Industry
- PSNY Auto Manufacturing
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- PSNY Consumer Discretionary
- RXRX Health Care
- Exchange
- PSNY Nasdaq
- RXRX Nasdaq
- Market Cap
- PSNY 2.4B
- RXRX 2.6B
- IPO Year
- PSNY N/A
- RXRX 2021
- Fundamental
- Price
- PSNY $1.10
- RXRX $4.18
- Analyst Decision
- PSNY Hold
- RXRX Buy
- Analyst Count
- PSNY 6
- RXRX 5
- Target Price
- PSNY $1.21
- RXRX $7.60
- AVG Volume (30 Days)
- PSNY 4.8M
- RXRX 21.3M
- Earning Date
- PSNY 05-12-2025
- RXRX 05-05-2025
- Dividend Yield
- PSNY N/A
- RXRX N/A
- EPS Growth
- PSNY N/A
- RXRX N/A
- EPS
- PSNY N/A
- RXRX N/A
- Revenue
- PSNY $2,034,261,000.00
- RXRX $59,790,000.00
- Revenue This Year
- PSNY $109.56
- RXRX $39.85
- Revenue Next Year
- PSNY $53.60
- RXRX $51.60
- P/E Ratio
- PSNY N/A
- RXRX N/A
- Revenue Growth
- PSNY N/A
- RXRX 29.32
- 52 Week Low
- PSNY $0.61
- RXRX $3.79
- 52 Week High
- PSNY $1.94
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- PSNY 50.70
- RXRX 40.49
- Support Level
- PSNY $1.00
- RXRX $3.96
- Resistance Level
- PSNY $1.18
- RXRX $4.69
- Average True Range (ATR)
- PSNY 0.07
- RXRX 0.29
- MACD
- PSNY -0.01
- RXRX 0.03
- Stochastic Oscillator
- PSNY 47.87
- RXRX 27.85
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.